Clinical Study

The Use of Strontium-90 Beta Radiotherapy as Adjuvant Treatment for Conjunctival Melanoma

Figure 3

(a) An 86-year-old patient with a de novo temporal conjunctival melanoma that was treated with excisional biopsy and cryotherapy and adjuvant strontium radiotherapy. (b) Seven years later, note the surgical corneal scar but no evidence of recurrence in the treated area. (c) A 69-year-old patient with a predisposing diagnosis of PAM with atypia developed an inferotemporal conjunctival melanoma that was subjected to excisional biopsy and cryotherapy and adjuvant strontium radiotherapy (d) 42 months later, no evidence of disease in the treated area. (e) A 72-year-old patient with a predisposing diagnosis of PAM with atypia developed a temporal conjunctival melanoma adjacent to the limbus that was treated with excisional biopsy and cryotherapy and adjuvant strontium radiotherapy. (f) Three years later, note the surgical corneal scar but no evidence of disease in the treated area.
349162.fig.003a
(a)
349162.fig.003b
(b)
349162.fig.003c
(c)
349162.fig.003d
(d)
349162.fig.003e
(e)
349162.fig.003f
(f)